Manhattan Beach Project

The "Manhattan Beach Project", a focused and targeted all-out assault on the human aging process, was spawned during an international scientific conference on June 23rd and 24th, 2000 in Manhattan Beach, California.

Similar to the "Manhattan Project", it set definite deadlines and ambitious goals. Unlike its namesake, the Manhattan Beach Project's goal is life enhancing... rather than life threatening.

And as opposed to the Manhattan Project, the Manhattan Beach Project will be a commercial enterprise driven by the private sector. It marries a scientific roadmap to intervene in the human aging process with LIVES™, a creative financial model to fund the research and development.

Our scientific model is endorsed by world renowned anti-aging scientists and gerontologists. Several give a 90% probability of reversing aging in lab mammals within 10 years with an annual budget of less than $100 million.

We plan on expanding that capability to aging in humans within 25 years.

During the process, MaxLife Capital's portfolio companies should develop several powerful anti-aging products and services aimed at the commercial market for human treatment or consumption.

Partners providing seed and roll-out funding will own the vast majority of the equity in the enterprises financed by the Fund. Partners neither invest nor donate. Instead, they make refundable deposits. MaxLife's innovative plan gives them a low-risk financial instrument with liquidity, annual income and potential high venture capital returns. Partners' deposits will be returned to them intact at the end of the project... or upon their withdrawal before the end the project's term.

Simply stated, our mission is...

Maximum Health & Longevity… In Minimum Time
And
Maximum Financial Returns… With Minimum Risk

Manhattan Beach Project Technology Descriptions:

Click on Deal Summaries

Manhattan Beach Project's Financial Description:

Click on LIVES™
Click on MaxLife Accelerator Fund

For a comprehensive project description, click on MaxLife Capital White Paper